3 completed, 1 active not recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Active not recruiting 1 |
Follow Localized Unresectable Neuroblastoma: new trials by email Literature Review of Localized Unresectable Neuroblastoma trials Research Report on Localized Unresectable Neuroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma Biopsy Procedure, Bone Marrow Aspiration, Bone Marrow Biopsy - Ganglioneuroblastoma, Localized Resectable Neuroblastoma | Phase 3 | Active not recruiting | Children's Oncology Group | 391 | 2014-08-08 | 2026-10-13 |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Autologous Hematopoietic Stem Cell Transplantation, Carboplatin, Cisplatin - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | Children's Oncology Group | 665 | 2007-11-05 | 2022-04-28 |
| Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Clinical Observation, Cyclophosphamide, Laboratory Biomarker Analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | Children's Oncology Group | 53 | 2004-03-15 | 2023-04-18 |
| Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Aldesleukin, Dinutuximab, Isotretinoin - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1449 | 2001-10-26 | 2026-03-05 |
Neuroblastoma (4) · Ganglioneuroblastoma (1)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Nerve Tissue (4) · Neoplasms, Neuroepithelial (4) · Neuroectodermal Tumors (4) · Neuroectodermal Tumors, Primitive (4) · Neuroectodermal Tumors, Primitive, Peripheral (4)
Cyclophosphamide (3) · Carboplatin (2) · Doxorubicin (2) · Etoposide (2) · Isotretinoin (2) · Magnetic Resonance Spectroscopy (2) · Observation (2) · Watchful Waiting (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Antibodies (1) · Biopsy (1) · Cisplatin (1) · Colony-Stimulating Factors (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1)
Children's Oncology Group (3) · National Cancer Institute (NCI) (1)
Australia (4) · Canada (4) · United States (4) · New Zealand (3) · Puerto Rico (3) · Saudi Arabia (1) · Switzerland (1)
Alice L Yu (1) · Holly J Meany (1) · Julie R Park (1) · Pedro A De Alarcon (1)
PMID 20879881, PMID 29376112, PMID 31454045, PMID 32530765, PMID 35839426, PMID 37883734, PMID 40036726
U10CA098543 (4), U10CA180886 (4), U10CA013539 (1), U10CA030969 (1)